Pharmacokinetics and Safety/Tolerability Profile of CKD-379

NCT05452525 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Type II Diabetes Mellitus

Interventions

DRUG: CKD-379 I
DRUG: CKD-379 II
DRUG: D759+D745+D150

Sponsor

Chong Kun Dang Pharmaceutical